Clinical trials: Therapeutic Treatment of Inhalation Anthrax
Infection, Bacterial, Anthrax
An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis
This field study is a post-marketing requirement from the FDA to evaluate the clinical benefit (course of illness and survival), safety and pharmacokinetics of obiltoxaximab administered to patients as part of their medical care…
- Trial name
- NCT03088111
- Testing
- Collection of samples, Obiltoxaximab
- Volunteers
- 100 people
- Sponsor
- Elusys Therapeutics
Inhalational Anthrax
A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients
This study will evaluate safety and clinical benefit of AIGIV used for treatment of patients with inhalational anthrax. This study will be implemented only in the event of a major anthrax exposure event.
- Trial name
- NCT03569553
- Testing
- AIGIV
- Volunteers
- 100 people
- Sponsor
- Emergent BioSolutions